Letters to the Editor

Pediatric blastic plasmacytoid dendritic cell neoplasms are molecularly defined by recurrent MYB rearrangements: clinical and molecular insights

Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Pediatric Oncology, Hospital de Câncer Infantojuvenil de Barretos, São Paulo
Department of Hematology/Oncology, Hospital Escuela de Niños de Honduras, Tegucigalpa, Honduras
Department of Pediatrics, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala
Department of Pediatric Oncology, Hospital Santo Antônio, Blumenau
Department of Pathology, Boston Children's Hospital, Boston, MA
Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Haematologica Early view May 7, 2026 https://doi.org/10.3324/haematol.2026.300903